Johan Raud
Company: Vicore Pharma
Job title: CSO
Seminars:
Analyzing the Phase 2a Open Label Study of an Angiotensin II Type 2 Receptor Agonists Improving Lung Function 12:30 pm
Highlighting the scientific rationale behind targeting angiotensin II type 2 receptor and how ATRAGs promotes alveolar repair Exploring an observed improvement in lung function highlighting the potential to halt disease progression, restore lung function and improve outcomesRead more
day: Day Two